VDCR as a treatment option for refractory or relapsed multiple myeloma in Bortezomib pretreated patients, a single center experience

被引：0
|
作者：
Dobrosch, L. [1 ]
Hahn-Ast, C. [1 ]
Mayer, K. [1 ]
von Lilienfeld-Toal, M. [1 ]
Brossart, P. [1 ]
Janzen, V [1 ]
机构：
[1] Univ Klinikum Bonn, Med Klin 3, Bonn, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P543
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [41] ANTITUMOR ACTIVITY OF BORTEZOMIB RETREATMENT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS
    Skvortsova, N.
    Pospelova, T.
    Nechunaeva, I.
    Kovalchuk, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 616 - 616
  • [42] Bortezomib in relapsed or refractory multiple myeloma:: results in a cohort of 39 patients
    Canovas Fernandez, A.
    Alonso Alonso, J. J.
    Barreiro Garcia, J. G.
    Aguirre Errasti, C.
    REVISTA CLINICA ESPANOLA, 2008, 208 (04): : 187 - 192
  • [43] Escalation treatment algorithm with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma: A singel centre experience.
    Fenk, Roland
    Michael, Mark
    Zohren, Fabian
    Graef, Thorsten
    Czibere, Arkosch
    Balleisen, Sebastian
    Neumann, Frank
    Rohr, Ulrich-Peter
    Steidl, Ulrich
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2006, 108 (11) : 1010A - 1010A
  • [44] ANTITUMOR ACTIVITY OF BORTEZOMIB RETREATMENT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS
    Skvortsova, N.
    Pospelova, T.
    Nechunaeva, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 590 - 590
  • [45] Bortezomib in relapsed/refractory multiple myeloma: A single-centre retrospective study on 45 patients
    Varettoni, M.
    Corso, A.
    Zappasodi, P.
    Mangiacavalli, S.
    Pica, G. M.
    Algarotti, A.
    Pascutto, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 150 - 150
  • [46] Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma
    Ahn, Jae-Sook
    Jung, Sung-Hoon
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [47] Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma
    Moreau, Philippe
    Chanan-Khan, Asher A.
    Roberts, Andrew W.
    Agarwal, Amit B.
    Facon, Thierry
    Kumar, Shaji
    Touzeau, Cyrille
    Cordero, Jaclyn
    Ross, Jeremy
    Munasinghe, Wijith
    Jia, Jia
    Salem, Ahmed H.
    Leverson, Joel
    Maciag, Paulo
    Verdugo, Maria
    Harrison, Simon J.
    BLOOD, 2016, 128 (22)
  • [48] Response to Bortezomib in relapsed/refractory multiple myeloma serie
    Rubio-Martinez, A.
    Recasens, V.
    Montanes, M. A.
    Mayayo, P.
    Delgado, P.
    Garcia-Zueco, J. C.
    Rubio-Felix, D.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 165 - 166
  • [49] Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma
    Lalagianni, C. E.
    Neokleous, N.
    Vadikoliou, C.
    Papalexandri, A.
    Apostolou, C.
    Saloum, R.
    Anagnostopoulos, A.
    Fassas, A.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S26 - S26
  • [50] BORTEZOMIB PLUS DEXAMETHASONE IN COMBINATION WITH MELPHALAN OR CYCLOPHOSPHAMIDE IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Tsirigotis, P.
    Girkas, K. G.
    Giannopoulou, V.
    Chondropoulos, S.
    Ioannidou, E.
    Papaxoinis, G.
    Pappa, V.
    Vasilatou, D.
    Dimoula, K.
    Kapodistrias, N.
    Papageorgiou, E.
    Economopoulos, T.
    Dervenoulas, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 436 - 436
12345